Biometrics: Conference

Showing posts with label Conference. Show all posts

Canadian Research Well Represented at HIV Prevention Conference

International conference in Cape Town attracts world-class research from Canada

WINNIPEG, Oct. 27, 2014 /CNW/ - A robust contingent of Canadian researchers will present their work this week at the HIV Research for Prevention (HIV R4P) Conference in Cape Town, South Africa.

The conference to be held from Oct. 28 to 31 is expected to attract up to 1,500 global leaders in HIV prevention, research, programs and policy. HIV R4P is the world's first and only scientific meeting dedicated exclusively to biomedical HIV prevention research.

Twenty nine oral and poster presentations will be made by Canadian researchers, 10 of whom received scholarships from the conference to present their work at HIV R4P. Presentation topics include: subject selection in HIV vaccine trials; the role of hormones in natural protection against HIV-1 in the Kenyan HIV-exposed seronegative cohort; and gay men involved in HIV — their concerns and hopes about pre-exposure prophylaxis (PrEP).

"The sample of Canadian research at HIV R4P is something we can celebrate," says Dr. Allan Ronald, senior scientific advisor of the Canadian HIV Vaccine Initiative (CHVI) Research and Development Alliance Coordinating Office (ACO). "It is also a testament to the ongoing international collaborations Canadian investigators have with researchers in other countries."

Among the Canadian presenters is Dr. Ken Rosenthal, a large team grant principal investigator whose work on innate, adaptive, and mucosal immune responses in HIV-1 exposed uninfected infants in South Africa is funded through the CHVI.

"The HIV R4P Conference is essentially looking at research for prevention, and Canada really has an important role to play in bringing HIV under control," says Rosenthal, who is also the first Visiting Scientist at the Cape Town HIV Vaccine Trials Network (HVTN) Immunology Laboratory. The state-of-the-art South African HIV vaccine research facility is supported by the Hutchinson Center Research Institute of South Africa (HCRISA), and funding for the laboratory's recent renovation was received from the Bill & Melinda Gates Foundation through the CHVI.

"The CHVI really is a driver for a number of reasons," Rosenthal says. "It builds linkages with investigators in developing countries which opens doors for Canadian research collaborations with colleagues in a global fashion."

Ronald adds that the CHVI has achieved some important outcomes since it started in 2007. "It has assisted with building regulatory capacity in low and middle-income countries, secured funding with the Canadian Institutes of Health Research (CIHR) and the Department of Foreign Affairs, Trade and Development (DFATD) for five collaborative scientific teams of Canadians with African colleagues, and facilitated with the Canadian private sector advances in the development of an HIV vaccine," he says.

The CHVI brings together five Government of Canada Departments/Agencies and the Bill & Melinda Gates Foundation to advance progress on HIV vaccine research and development efforts. It also contributes to the prevention of mother-to-child transmission. The establishment of the ACO at the International Centre of Infectious Diseases in Winnipeg in 2011 has facilitated information exchange, collaboration and coordination across diverse national and international research efforts.

SOURCE Alliance Coordinating Office

RELATED LINKS
http://www.alliance-aco.ca

reade more...

Xencor to Present at Jefferies 2014 Global Healthcare Conference

MONROVIA, Calif., May 22, 2014 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, today announced that Bassil Dahiyat, Ph.D., president and chief executive officer, will present at the Jefferies 2014 Global Healthcare Conference on Thursday, June 5, 2014 at 8:00 a.m. EDT in New York City, NY.

A live audio webcast of the presentation will be available on the "Events and Presentations" section in the Investors section of the company's website located at http://investors.xencor.com/events.cfm. A replay of the presentation will be posted on the Xencor website approximately one hour after the event and will be available for 30 days following the presentation.

About Xencor, Inc.
Xencor is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer. Currently, six candidates are in clinical development internally and with partners that have been engineered with Xencor's XmAb® technology. Xencor's internally-discovered programs include XmAb5871 in Phase 1b/2a clinical trials for the treatment of Rheumatoid arthritis and lupus, XmAb7195 in preclinical development for the treatment of asthma, and XmAb5574/MOR208 which has been licensed to Morphosys AG and is in Phase 2 clinical trials for the treatment of acute lymphoblastic leukemia and non-Hodgkin lymphoma. Xencor's XmAb antibody engineering technology enables small changes to the structure of monoclonal antibodies resulting in new mechanisms of therapeutic action. Xencor partners include Amgen, Merck, Janssen R&D LLC, Alexion and Boehringer Ingelheim.

For more information, please visit www.xencor.com.

SOURCE Xencor

ValidSoft's CEO Paul Burmester Joins "The Future of Secure, Mobile Authentication" Panel at Opus Research's Voice Biometrics Conference San Francisco 2014

ValidSoft's logo. (PRNewsFoto/ValidSoft)jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";LONDON and SAN FRANCISCO, May 14, 2014 /PRNewswire/ -- ValidSoft (www.validsoft.com), a global supplier of transaction authentication solutions utilized by banks, financial services companies and enterprise customers to secure and authorize transactions of all types, and an Elephant Talk Communications Corp. (NYSE MKT: ETAK) company, today announced that Paul Burmester, CEO of ValidSoft, is taking part in a panel discussion entitled "The Future of Secure, Mobile Authentication" at the Opus Research Voice Biometrics Conference held at the Fairmont Hotel San Francisco on May 14th and 15th. Opus Research's Voice Biometrics Conference ("VBC") is the premier global event tackling the issues and opportunities for phone-based security and multi-factor authentication.

VBC San Francisco 2014 showcases the ever-expanding set of current solutions and future opportunities for voice biometrics and phone-based technologies to support strong authentication and fraud prevention in contact centers, inside mobile devices and to enable secure commerce. Mr. Burmester is joined on the panel by a number of leading industry experts including Kayvan Alikhani, Senior Director of Technology, RSA, Emilio Martinez, Chief Executive Officer, Agnitio and Larry Koved of IBM Research.

"It's a very exciting time to be involved in 'Biometrics' as it enters the mainstream and user adoption accelerates, especially around the application of voice technology which leads the field in terms of ease of use," said Paul Burmester. "Today, we're focusing on integrating our Voice Biometric engine as part of a multi-factor authentication solution, balancing ease of use with security. Through events such as Opus' Voice Biometrics Conference, we have the ability to meet with our industry peers and work together to apply this technology towards new and exciting applications."

About ValidSoft UK Limited:
ValidSoft UK Limited ("ValidSoft") provides advanced mobile and cloud-security solutions. ValidSoft's custom-built sophisticated multi-factor authentication platform (SMART™) takes full advantage of telecommunications and includes a leading proprietary voice biometric engine. The platform combats electronic fraud and safeguards consumer privacy across internet, mobile banking, card, mobile and fixed line telecommunication channels. The company counts some of the largest financial institutions among its customers. ValidSoft is the only security software company in the world that has been granted three European Privacy Seals. Visit: www.validsoft.com.

About Elephant Talk Communications:
Elephant Talk Communications Corp. (NYSE MKT: ETAK), is a global provider of mobile proprietary Software Defined Network Architecture (ET Software DNA® 2.0) platforms for the telecommunications industry. The Company empowers Mobile Network Operators (MNOs), Mobile Virtual Network Operators (MVNOs), Enablers (MVNEs) and Aggregators (MVNAs) with a full suite of applications, superior industry expertise and high quality customer service without the need for substantial upfront investment. Elephant Talk counts several of the world's leading Mobile Network Operators amongst its customers, including Vodafone, T-Mobile, Zain and Iusacell. Visit: www.elephanttalk.com.

Media Contacts:

Investor Relations:
Steve Gersten
Elephant Talk Communications Corp.
+ 1 813 926 8920
Steve.Gersten@validsoft.com

Thomas Walsh
Alliance Advisors
+ 1 212 398 3486
twalsh@allianceadvisors.net

US: Michael Glickman
MWG CO
+1 917 596 1883
mike@mwco.net

Logo - http://photos.prnewswire.com/prnh/20120917/MM75492LOGO
Logo - http://photos.prnewswire.com/prnh/20120917/MM75872LOGO

SOURCE ValidSoft

Biophotonics Conference and Exhibition strategies Announces speakers

PennWell Corp. is a business-to-business communication and information media diversified company that provides quality content and integrated marketing solutions for the following industries: electricity, water and wastewater, oil and gas, renewable,... jwplayer. key = ' 2k?/GKwZ2uQZmDlQ9VYArfZt2b4 + KhHX3 + DM4zisgtE = ";NASHUA, New Hampshire, 10 April 2014/PRNewswire /-strategies in Biophotonics Announces speakers for the meeting in Boston, September 9-11. This new Conference with exhibition brings together an outstanding group of rapporteurs who have been involved in the development and marketing of products based on optics and Photonics and biomedical technologies.

Speakers include:

Robert S. Langer, Professor of ScD, MIT Institute, whose patents have been approved by more than 250 pharmaceutical, chemical, biotechnology and medical devices: creation and implementation of advanced technologies. David Walt, PhD, Tufts and HHMI Professor and co-founder of Illumina, the first sequencing of the DNA of the company to achieve the genome $1000: lessons learned from taking discoveries from the academic laboratory through marketing. Ellen Strahlman,MD, Corporation, Senior Vice President of R & D and Chief Medical Officer at BD Biosciences: meeting market needs with innovation. Gregory Altshuler, PhD, DSc, Senior Vice President of R & D at the Palomar Medical: creation of new products for life science markets.In addition, well-known leaders in their fields will address issues ranging from the role of optics and Photonics in the life science market to global opportunities in the trends towards the point of care and mobile health services.

These speakers are:

Robert Alfano, PhD, Director of the Institute for ultrafast spectroscopy & laser, City College of the city of New York, referring to the light advances in biomediphotonics Anita Goel, MD, PhD, CEO of Nanobiosym and winner of the Nokia XChallenge, talks about personalized medicine and global health Robert Nordstrom, PhD, Program Director of the program of the NIH cancer imaging, speaking in translating ideas Biophotonics in commercial utility Joseph SchmittPhD, Vice President of development advanced in St. Jude Medical, talking about the marketing diagnosis, Amy Kerdok, PhD, Director of development at Intuitive Surgical clinical engineering, discusses lessons learned optical integrator in surgical robots Myron Greenspan, lawyer of Lackenbach Siegel LLP, about what you should know about property intellectual and patent law two panels innovative experts:

Fabian d ' Souza, MD, President of Boston partners, leads a discussion with physicians, including John Frangioni, MD and Penny Ford-Carleton, RN, MS, meet your requirement with heads of John Dexheimer, counsel to the President of LightWave, optical technologies and photonics, a group of investors to provide knowledge on financing and acquisition strategies "are very excited to have such distinguished speakers from a through a variety of doctors and fields of technology of the Academy", business, finance and Government, "said Barbara Goode, co-Chair of the Conference and Editor in Chief of the BioOptics World."I think that assistants are valuable resources and knowledge, as we combine a truly unique and diverse group of people who are involved in the development and commercialization of Biophotonics-based products that are revolutionizing the Sciences of life."

Strategies in Biophotonics Conference and Exhibition is the only event dedicated to enable successful market and product development of biomedical technologies and products based on optics and photonics. It will be held at the Boston Park Plaza Hotel from 9 to 11 September 2014.

The event is owned and produced by PennWell and is organized by BioOptics and Laser Focus world. To register online and to learn more about strategies in Biophotonics, visit: www.strategiesinbiophotonics.com.

About PennWell
PennWell Corp. It is a business-to-business communication and information media diversified company that provides quality content and solutions for the following industries of integrated marketing: optoelectronics, fiber optics, electric power, water and wastewater, oil and gas, renewable, electronics, semiconductors, control of pollution, enterprise storage, convert, nanotechnology, fire, emergency services and dental. Founded in 1910, PennWell publishes over 100 print and online magazines and newsletters, performs 60 conferences and exhibitions on six continents and has a wide range of books, maps, web sites, research and database services. In addition to PennWell in Tulsa, Oklahoma, headquarters the company has main offices in Nashua, New Hampshire; Houston, Texas; London, England; Mountain View, California; Fairlawn, New Jersey, Moscow, Russia and Hong Kong, China. In 2010, PennWell celebrates 100 years in business.

Contact:
Amanda Brumby
Marketing manager
Amandab@PennWell.com
352-804-9091

Logo - http://photos.prnewswire.com/prnh/20110627/DA26630LOGO

SOURCE PennWell Corp.

New York Healthcare Real Estate Conference - April 8 New York City: Join the Nation's Largest Healthcare Real Estate Investors, Developers, Capital Sources

"Healthcare real estate is now the darling of the industry. Learn more on April 8 during Healthcare & Real Estate 2014," Michael A. Noto , Senior Vice President--Management Services Group, Health Care REIT. (PRNewsFoto/CAPRATE Events)jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";NEW YORK, March 26, 2014 /PRNewswire-iReach/ -- Healthcare real estate is a hot real estate asset class in 2014! But just how hot and how real are the opportunities? Join the expected 400+ as we separate fact from fiction (and hype) at Healthcare & Real Estate 2014 on April 8 in New York.

Photo - http://photos.prnewswire.com/prnh/20140326/MN90408

Healthcare & Real Estate 2014 will bring together the most active and innovative national healthcare providers and real estate executives for vital discussion debate and networking. The opening panel "Healthcare Real Estate 20/20" will provide clear vision of the market today. The industry's top investors, developers, and healthcare providers will offer their thoughts on the many opportunities and challenges in the market. The many panels that follow will go beyond the headlines with pointed analysis and commentary on financing, the emergence of new investors and general healthcare service trends. Join 40+ speakers and the expected 400+ attendees for Healthcare & Real Estate 2014 on April 8.

> For additional information, including detailed agenda and registration: www.cre-events.com/hcre2014

Hear Active & Innovative Healthcare & Real Estate Executives, Including:
* Steve Anderson, Senior Vice President, Capital One Commercial and Specialty Finance
* Charles "Chick" Atkins, Principal, Atkins Companies
* James D. Bremner, President – Healthcare, Duke Realty
* Mark Burkemper, Senior Vice President, Harrison Street Real Estate Capital, LLC
* Jeffrey H Cooper, Chairman & Executive Managing Director, Savills
* Jeffrey P. Drucker, AIA, Vice President and Studio Director, Northeast Region, ARRAY
* Ciro Fraschilla, AIA, President & Chief Executive Officer, Mascioni & Behrmann, Architecture & Engineering, P.C.     * Wilkingson Germain, Investment Officer, Ventas, Inc.
* Scot Glasberg, MD, President Elect, American Society of Plastic Surgeons
* Morris Gross, Vice President – Facilities Management, Danbury Hospital    Amanda Houghton, Executive Vice President – Asset Management, Healthcare Trust of America, Inc.
* Todd Jensen, Chief Investment Officer, American Realty Capital Healthcare Trust
* Arthur Klein, MD, President, The Mount Sinai Health Network
* Christopher W. Korsh, Senior Principal – Regional Leader, Healthcare, HOK
* David P. Lari, Partner, Cox Castle Nicholson
* Steven Laufer, President, Promenade Senior Living
* Sean P. Leyden, Partner/Director, Garfunkel Wild, P.C.
* H. Guy Leibler, President, Simone Healthcare Development
* Andrew Lawler, Partner, Healthcare Development, The Keith Corporation
* John Marshall, Vice President, Duke Realty
* Chan-li Lin, Partner, Rafael Vinoly Architects
* Beth Burnham Mace, Chief Economist and Director of Capital Markets Outreach, National Investment Center for the Seniors Housing and Care Industry (NIC)
* Norman K. Livingston, Managing Partner, Founder, Norvin Partners, Ltd
* Scott A. Mason, D.P.A, FACHE, Executive Managing Director and Leader | Healthcare, Cushman & Wakefield
* Chris Montello, Principal, MP Healthcare Services
* Casey N. Moore, Principal, Prudential Mortgage Capital
* Jared Morgan, Vice President – Investments, SPIRIT Realty Capital
* Ken Music, Regional Manager, Bank of America
* Max Newland, Director – Acquisitions, Kayne Anderson Real Estate
* Michael A. Noto, Senior Vice President—Management Services Group, Health Care REIT
* Gary Sastow, Law Offices of Gary S. Sastow, PLLC
* Ronald M. Shapiro, Administrative Director, Rutgers Business School Center for Real Estate Studies

* James F Sherman, Executive Vice President – Seniors Housing, Beech Street Capital
* Frank R. Williams, Jr., Senior Managing Director – Acquisitions, Medical Properties Trust, Inc.
* Paul Wexler, Wexler Healthcare Properties, The Corcoran Group
* Salley Whitman, Co-Founder & Executive Director, NXT Health
* Jonathan L. Winer, Senior Managing Director and Chief Investment Officer, Seavest Healthcare Properties, LLC
* Murray Wolf, Publisher, Healthcare Real Estate Insights
* Laca Wong Hammond, Head of Healthcare Real Estate – Healthcare Investment Banking, Raymond James

* Jonathan Buehner, GE Capital Healthcare Financial Services
* Paul N. Orloff, MD, President, New York County Medical Society

NETWORKING & NEW BUSINESS DEVELOPMENT: 225 leading CRE and healthcare executives from 95 firms have already made plans to attend. Attending firms, as of March 24, 2014:
* AFD Contract Furniture Inc.
* American Realty Capital
* American Society of Plastic Surgeons
* Andersen Environmental
* Arbor Commercial Mortgage
* ARRAY
* Array Architects
* Atkins Companies
* Bank of America
* Beech Street Capital
* Bergman Real Estate Group
* Bohler Engineering
* Capital One
* Caracor LLC
* CBRE
* Cox, Castle & Nicholson LLP
* CTL Capital
* Cushman & Wakefield
* Danbury Hospital
* Dare Living Associates
* Duke Realty
* EmblemHealth, Inc.
* EwingCole
* First Columbia Property Services
* Garfunkel Wild, P.C.
* GE Capital – Healthcare Financial Services
* Gilsanz Murray Steficek, LLP
* Grassi & Co.
* Harrison Street Real Estate Capital, LLC
* Health Care REIT, Inc.
* HealthAmerica Realty Group
* Healthcare Real Estate Insights
* Healthcare Trust of America, Inc.
* HFF
* HOK
* JFK&M Consulting Group
* Kayne Anderson Real Estate
* Kings III Emergency Communications
* Law Offices of Gary S. Sastow, PLLC
* LifeQuest
* Lillibridge Healthcare Services
* LJS Real Estate Services
* LotInfo LLC
* LPCiminelli
* Marcus & Millichap Real Estate Investment Services
* Mascioni & Behrmann, Architecture & Engineering, P.C.
* MB Real Estate
* MedDev LLC
* Medical Properties Trust, Inc.
* Memorial Sloan Kettering Cancer Center
* Meritage Properties LLC
* Montefiore
* MP Healthcare Services
* NAI JAMES E. HANSON
* National Investment Center for the Seniors Housing and Care Industry (NIC)
* Nelin Real Estate Management, Inc.
* New York County Medical Society
* Newmark Associates, Commercial Real Estate Services
* NIC
* NK Architects
* NK Associates
* Norvin Partners, Ltd
* NPV Advisors
* NXT Health
* OMNInteriors
* Penn Real Estate Group
* Perkins+Will
* Platinum Health Care, LLC
* Promenade Senior Living
* Prudential Mortgage Capital
* Prudential Mortgage Capital Company
* Rafael Vinoly Architects
* Raymond James
* Rutgers Business School Center for Real Estate Studies
* Savills LLC
* Seavest Healthcare Properties, LLC
* Simone Development
* Simone Healthcare
* Simone Healthcare Development
* Simpson Gumpertz & Heger
* Spirit Realty Capital Inc.
* Stan Johnson Company
* Starwood Capital Group
* Stephen Yablon Architect
* Suburban Hospital Alliance
* Suffolk Construction Co., Inc.
* The Keith Corporation
* The Mount Sinai Health Network
* The Real Deal
* Trammell Crow Company
* Vanderweil Engineers
* Ventas, Inc.
* Voikos Construction Management
* Westage Companies
* Wexler Healthcare Properties, The Corcoran Group
* Windels Marx Lane & Mittendorf, LLP
* Yang & Associates, P.C.

Event Speaker/Sponsor Contact: Brian Klebash | 917-460-3572 | info@cre-events.com

CapRate Events/CRE-Events.com is an independently-owned and operated digital media firm based in New York City. Launched in June of 2011, the firm has emerged as a new leader in commercial real estate informational and networking services.

Media Contact: Brian Klebash, CAPRATE Events, LLC, 6175016075, info@cre-events.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE CAPRATE Events

reade more...

Healthcare Real Estate Conference New York: Join Leading Investors, Developers, Capital Sources & Healthcare Executives on April 8; Look Who's Attending

"As a real estate investor and a student of the health education program at Columbia University, I was looking forward to Healthcare & Real Estate with much anticipation. The event turned out to be more than I expected: exceptionally ...jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";NEW YORK, March 20, 2014 /PRNewswire-iReach/ -- If you are active in healthcare real estate investment, development and financing around the nation, you will not want to miss HEALTHCARE & REAL ESTATE 2014 on April 8 in New York. Join 40 speakers in 12 panel discussions and the expected 400+ attendees for discussion, debate and networking. Explore New Healthcare Real Estate, Medical Office Building and Research Facility Investment, Development & Financing Opportunities in Greater New York. HEALTHCARE & REAL ESTATE 2014 will bring together the leading national and Tri-State healthcare real estate executives, healthcare providers and industry service providers for a full-day market intelligence and networking program on April 8.

(Photo: http://photos.prnewswire.com/prnh/20140320/MN86779)

Confirmed Speakers: Hear New Voices & Expert Industry Analysts:

* Mark Burkemper, Senior Vice President, Harrison Street Real Estate Capital, LLC
* Jeffrey H Cooper, Chairman & Executive Managing Director, Savills
* Jeffrey P. Drucker, AIA, Vice President and Studio Director, Northeast Region, ARRAY
* Ciro Fraschilla, AIA, President & Chief Executive Officer, Mascioni & Behrmann, Architecture & Engineering, P.C.
* Wilkingson Germain, Investment Officer, Ventas, Inc.
* Morris Gross, Vice President – Facilities Management, Danbury Hospital
* Todd Jensen, Chief Investment Officer, American Realty Capital Healthcare Trust
* Christopher W. Korsh, Senior Principal – Regional Leader, Healthcare, HOK
* Steven Laufer, President, Promenade Senior Living
* Sean P. Leyden, Partner/Director, Garfunkel Wild, P.C.
* H. Guy Leibler, President, Simone Healthcare Development
* John Marshall, Vice President, Duke Realty
* Scott A. Mason, D.P.A, FACHE, Executive Managing Director and Leader | Healthcare, Cushman & Wakefield
* Chris Montello, Principal, MP Healthcare Services
* Casey N. Moore, Principal, Prudential Mortgage Capital
* Max Newland, Director – Acquisitions, Kayne Anderson Real Estate
* Paul N. Orloff, MD, President, New York County Medical Society
* Ted A. Petrillo, Principal, Westage Companies
* Gary Sastow, Law Offices of Gary S. Sastow, PLLC
* Frank R. Williams, Jr., Senior Managing Director – Acquisitions, Medical Properties Trust, Inc.
* Paul Wexler, Wexler Healthcare Properties, The Corcoran Group
* Salley Whitman, Co-Founder & Executive Director, NXT Health
* Jonathan L. Winer, Senior Managing Director and Chief Investment Officer, Seavest Healthcare Properties, LLC
* Laca Wong Hammond, Head of Healthcare Real Estate – Healthcare Investment Banking, Raymond James

For detailed agenda and registration: www.cre-events.com/HCRE2014

Participating investors, developers & owners as of March 11, include:

* American Realty Capital
* Harrison Street Real Estate Capital, LLC
* Health Care REIT, Inc.
* Healthcare Trust of America, Inc.
* Kayne Anderson Real Estate
* Lillibridge Healthcare Services
* MB Real Estate
* MedDev LLC
* Medical Properties Trust, Inc.
* Meritage Properties LLC
* Seavest Healthcare Properties, LLC
* Simone Development / Simone Healthcare
* Ventas, Inc.
* Westage Companies (partial list)

HEALTHCARE & REAL ESTATE 2014 will feature 40 speakers, including new voices and industry experts in 12 panel discussions. Agenda coverage:
* The new and changing delivery of healthcare in 2014: What's new in healthcare delivery?
* Urgent care centers update: Are they here to stay?
* Healthcare legal analysis: What are the legal ramifications of the accountable care act?
* Is the private practice of medicine going the way of the dinosaur? Who will survive and who may become extinct?
* New innovations in healthcare: What are the most profitable medical services being provided today?
* A study of healthcare design today and the efficiencies of multiple care facilities: Exploring the Importance of efficient health care design in today's multi-specialty healthcare spaces
* Investment trends in healthcare real estate, including hospitals, medical office buildings and research facilities: Who is investing in healthcare real estate today?

"The current transformation of the delivery of healthcare services from a provider oriented system to a patient centric system is revolutionizing where, how, and who is now providing healthcare services. Come learn the latest trends in healthcare real estate today: who is doing the deals, where the deals are being done, and why what is happening affects every one of us."- Paul Wexler, Wexler Healthcare Properties, The Corcoran Group

For detailed agenda and registration: www.cre-events.com/HCRE2014

AFD Contract Furniture Inc. American Realty Capital Arbor Commercial Mortgage ARRAY Array Architects Bank of America Beech Street Capital Bergman Real Estate Group Capital One Caracor LLC CBRE Cox, Castle & Nicholson LLP CTL Capital Cushman & Wakefield Danbury Hospital Dare Living Associates Duke Realty EmblemHealth, Inc. EwingCole First Columbia Property Services Garfunkel Wild, P.C. GE Capital – Healthcare Financial Services Gilsanz Murray Steficek, LLP Harrison Street Real Estate Capital, LLC Health Care REIT Health Care REIT, Inc. HealthAmerica Realty Group Healthcare Real Estate Insights HFF HOK JFK&M Consulting Group Kayne Anderson Real Estate Kings III Emergency Communications Law Offices of Gary S. Sastow, PLLC LifeQuest Lillibridge Healthcare Services LJS Real Estate Services LotInfo LLC LPCiminelli Marcus & Millichap Real Estate Investment Services Mascioni & Behrmann, Architecture & Engineering, P.C. MB Real Estate MedDev LLC Medical Properties Trust, Inc. Memorial Sloan Kettering Cancer Center Meritage Properties LLC Montefiore MP Healthcare Services NAI JAMES E. HANSON New York County Medical Society NIC NK Architects NPV Advisors NXT Health Penn Real Estate Group Platinum Health Care, LLC Promenade Senior Living Prudential Mortgage Capital Prudential Mortgage Capital Company Raymond James Savills Savills LLC Seavest Healthcare Properties, LLC Simone Development Simone Healthcare Simone Healthcare Development Spirit Realty Capital Inc. Stan Johnson Company Starwood Capital Group Stephen Yablon Architect Suburban Hospital Alliance Suffolk Construction Co., Inc. The Keith Corporation Ventas, Inc. Voikos Construction Management Westage Companies Wexler Healthcare Properties, The Corcoran Group Windels Marx Lane & Mittendorf, LLP Yang & Associates, P.C.
Event Speaker/Sponsor Contact: Brian Klebash | 917-460-3572 | info@cre-events.com
Telephone Registration/Questions: Ronnie Niederman | 212-873-3484

For more information or to get involved: info@cre-events.com | www.cre-events.com

Media Contact: Brian Klebash, CAPRATE Events, LLC, 6175016075, info@cre-events.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE CAPRATE Events, LLC

Regulus to Present at Cowen and Company 34th Annual Healthcare Conference

LA JOLLA, Calif., Feb. 26, 2014 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that Kleanthis G. Xanthopoulos, Ph.D., President and Chief Executive Officer of Regulus, will present a company overview at the Cowen and Company 34th Annual Healthcare Conference on Wednesday, March 5, 2014 at 10:40 am EST. The conference is being held at the Boston Marriott Copley Place.

The presentation will be webcast at the time of the presentation and can be accessed on the Investor Relations page of the Company's website at www.regulusrx.com. A replay of the webcast will be archived on the Company's website following the presentation date.

About Regulus

Regulus Therapeutics Inc. (NASDAQ: RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus is uniquely positioned to leverage a mature therapeutic platform that harnesses the oligonucleotide drug discovery and development expertise of Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc., which founded the company. Regulus has a well-balanced microRNA therapeutic pipeline entering clinical development, an emerging microRNA biomarkers platform to support its therapeutic programs, and a rich intellectual property estate to retain its leadership in the microRNA field. Regulus intends to focus its proprietary efforts on developing microRNA therapeutics for oncology indications and orphan diseases and is currently advancing several programs toward clinical development in oncology, fibrosis and metabolic diseases. Specifically, Regulus is developing RG-012, an anti-miR targeting microRNA-21 for the treatment of Alport Syndrome, a life-threatening kidney disease driven by genetic mutations with no approved therapy, and RG-101, a GalNAc-conjugated anti-miR targeting microRNA-122 for the treatment of chronic hepatitis C virus infection. Regulus' commitment to innovation and its leadership in the microRNA field have enabled the formation of strategic alliances with AstraZeneca, GlaxoSmithKline and Sanofi. In addition, the Company has established Regulus microMarkers™, a research and development division focused on identifying microRNAs as biomarkers of human disease, which is designed to support its therapeutic pipeline, collaborators and strategic partners.

For more information, please visit http://www.regulusrx.com.

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements associated with Regulus' expectations regarding future therapeutic and commercial potential of Regulus' business plans, technologies and intellectual property related to microRNA therapeutics being discovered and developed by Regulus. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "intends," "will," "goal," "potential" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Regulus' current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, which include, without limitation, risks associated with the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs. These and other risks concerning Regulus' programs are described in additional detail in Regulus' SEC filings. All forward-looking statements contained in this press release speak only as of the date on which they were made. Regulus undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

SOURCE Regulus Therapeutics Inc.

New York City Healthcare Real Estate Conference: ARC, Danbury Hospital, Kayne Anderson Real Estate, Morgan Keegan & More: Add Your Firm to this Influential List of Speakers & Attendees

HEALTHCARE & REAL ESTATE 2014 will bring together the leading national and Tri-State healthcare real estate executives, healthcare providers and industry service providers for a full-day market intelligence and networking program. 400+ are ...jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";NEW YORK, Feb. 21, 2014 /PRNewswire-iReach/ -- New Investors, New Developers, New Strategies & New Stories: Healthcare & Real Estate 2014 will bring together 300+ attendees and 40 Speakers in 12 panel discussions. Join the most active investors, developers, capital sources, brokers, tenants, healthcare providers and technology firms for an important and in-depth healthcare & real estate update on April 8. Healthcare & Real Estate 2014 is New York's largest regional one-day conference focused exclusively on healthcare and real estate in New York, New Jersey and Connecticut.

(Photo: http://photos.prnewswire.com/prnh/20140221/MN69271)

HEALTHCARE & REAL ESTATE 2014

will feature 40 speakers, including new voices and industry experts in 12 panel discussions. Agenda coverage:
* The new and changing delivery of healthcare in 2014: What's new in healthcare delivery?
* Urgent care centers update: Are they here to stay?
* Healthcare legal analysis: What are the legal ramifications of the accountable care act?
* Is the private practice of medicine going the way of the dinosaur? Who will survive and who may become extinct?
* New innovations in healthcare: What are the most profitable medical services being provided today?
* A study of healthcare design today and the efficiencies of multiple care facilities: Exploring the Importance of efficient health care design in today's multi-specialty healthcare spaces
* Investment trends in healthcare real estate, including hospitals, medical office buildings and research facilities: Who is investing in healthcare real estate today?

> View detailed agenda: http://cre-events.com/hcre2014/agenda/

"As a real estate investor and a student of the health education program at Columbia University, I was looking forward to Healthcare & Real Estate with much anticipation. The event turned out to be more than I expected: exceptionally well-organized with the highest caliber panelists whom I had the pleasure of speaking with during the breaks following the discussions. I learned about the pros and cons of entering the field and gained an in-depth view of the marketplace." - Renata Robel-Becker, TRB Investment Group, LLC

Confirmed Speakers: Hear 40 Speakers, Including New Voices & Industry Experts

* John D. Claybrook, Partner, Waller Lansden Dortch & Davis, LLP
* Jeffrey H Cooper, Chairman & Executive Managing Director, Savills
* Morris Gross, Vice President – Facilities Management, Danbury Hospital
* Todd Jensen, Chief Investment Officer, American Realty Capital Healthcare Trust
* Steven Laufer, President, Promenade Senior Living
* John Marshall, Vice President, Duke Realty
* Scott A. Mason, D.P.A, FACHE, Executive Managing Director and Leader | Healthcare, Cushman & Wakefield
* Casey N. Moore, Principal, Prudential Mortgage Capital
* Max Newland, Director – Acquisitions, Kayne Anderson Real Estate
* Frank R. Williams, Jr., Senior Managing Director – Acquisitions, Medical Properties Trust, Inc.
* Paul Wexler, Wexler Healthcare Properties, The Corcoran Group
* Jonathan L. Winer, Executive Vice President, Seavest Inc.
* Laca Wong Hammond, Head of Healthcare Real Estate – Healthcare Investment Banking, Raymond James | Morgan Keegan
* Wilkingson Germain, Investment Officer, Ventas, Inc. (tentative)

> View detailed agenda: http://cre-events.com/hcre2014/agenda/

Paul Wexler, Wexler Healthcare Properties at The Corcoran Group

NETWORKING & NEW BUSINESS DEVELOPMENT: 135 leading CRE and healthcare executives have already made plans to attend - Add your firm's name to this influential list today. 300+ are expected to attend. Attending firms, as of February 19, 2014:
* Arbor Commercial Mortgage
* Array Architects
* Beech Street Capital
* CapRate Events
* Caracor LLC
* CBRE
* Cushman & Wakefield
* Danbury Hospital
* Dare Living Associates
* Duke Realty
* EmblemHealth, Inc.
* LifeQuest
* Lillibridge Healthcare Services
* Marcus & Millichap Real Estate Investment Services
* MedDev LLC
* Medical Properties Trust, Inc.
* NAI JAMES E. HANSON
* NPV Advisors
* Promenade Senior Living
* Prudential Mortgage Capital
* Raymond James | Morgan Keegan
* Savills
* Seavest Inc.
* Simone Development
* Simone Healthcare
* Ventas, Inc.
* Voikos Construction Management
* Voikos Construction Management
* Waller Lansden Dortch & Davis, LLP
* Westage Companies
* Westage Companies
* Wexler Healthcare Properties
* Windels Marx Lane & Mittendorf, LLP

> View official conference website: http://cre-events.com/hcre2014/

> Register for this event today: https://www.regonline.com/Register/Checkin.aspx?EventID=1482046

Event Speaker/Sponsor/Exhibitor Contact: Brian Klebash | 917-460-3572 | info@cre-events.comTelephone Registration/Questions: Ronnie Niederman | 212-873-3484

For more information or to get involved: www.cre-events.com |info@cre-events.com | 917-460-3572

Media Contact: Brian Klebash, CAPRATE Events, LLC, 6175016075, info@cre-events.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE CAPRATE Events

reade more...

BioNano Genomics To Present At Upcoming J.P. Morgan Healthcare Conference

SAN DIEGO, Jan. 10, 2014 /PRNewswire/ -- BioNano Genomics announced today that Erik Holmlin, Ph.D., BioNano's president and CEO, will present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 16th at 12:00 p.m. PST.

About BioNano Genomics

Headquartered in San Diego, BioNano Genomics is delivering an altogether better way of gaining a fully informed understanding of genomes. The Company's platform, the Irys® System, provides researchers and clinicians the most comprehensive, organized and actionable picture of a genome with unprecedented insights into how the individual components of genomes are ordered, arranged, and interact with each other. BioNano Genomics works with institutions in life science, translational research, molecular diagnostics and personalized medicine. The Company is supported by private investors and grant funding from genomics programs at federal agencies, including the NIH and NIST-ATP.

www.BioNanoGenomics.com

Notes: BioNano Genomics is a trademark of BioNano Genomics, Inc. Any other names of actual companies, organizations, entities, products or services may be the trademarks of their respective owners.

SOURCE BioNano Genomics

RELATED LINKS
http://www.BioNanoGenomics.com

reade more...

Organovo to Present at the 25th Annual Piper Jaffray Healthcare Conference

SAN DIEGO, Nov. 19, 2013 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) (" Organovo "), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, has been invited to present at the 25th Annual Piper Jaffray Healthcare Conference, which will be held in New York December 3-4, 2013.

Organovo's Chairman and Chief Executive Officer, Keith Murphy, will be presenting on Wednesday, December 4, at 3:30pm ET Mr. Murphy will also be participating in a panel discussion on 3D Printing on Tuesday, December 3, at 2:00pm ET.

The goal of Piper Jaffray's 25th Annual Healthcare Conference is to bring together key industry executives, investors and Piper professionals to provide multiple perspectives, investigate critical trends and identify the leaders in the markets that are driving our economy. The conference will be held at The New York Palace – New York.

About Organovo Holdings, Inc.

Organovo designs and creates functional, three-dimensional human tissues for medical research and therapeutic applications. The Company is collaborating with pharmaceutical and academic partners to develop human biological disease models in three dimensions. These 3D human tissues have the potential to accelerate the drug discovery process, enabling treatments to be developed faster and at lower cost. In addition to numerous scientific publications, the Company's technology has been featured in The Wall Street Journal, Time Magazine, The Economist, and numerous others. Organovo is changing the shape of medical research and practice. Learn more at www.organovo.com.

Safe Harbor Statement

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; and the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies. These and other factors are identified and described in more detail in our filings with the SEC, including our report on Form 10-Q filed November 8, 2013, the prospectus supplement filed with the SEC on August 2, 2013 and the transition report on Form 10-KT filed with the SEC on May 24, 2013 and our other filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances or to reflect the occurrence of unanticipated events.

SOURCE Organovo Holdings, Inc.

Pages

.